Updated
VeracyteVCYT · Healthcare
$24.16+0.67%
Market cap$1.9B
IndustryDiagnostics & Research

Veracyte (VCYT) Superinvestor holders

17 of the superinvestors we track hold Veracyte (VCYT) in their latest 13F filings, $671M in total.

Summary

The largest holder is Artisan Partners, with $325M, 0.5% of the portfolio.

In their latest quarter: 6 added, 10 trimmed.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
Artisan Partners Added 5,538,404$325M 0.5%Q2 2026
Cathie Wood
ARK Investment Management
Trimmed 2,295,951$135M 0.9%Q2 2026
Steve Cohen
Point72 Asset Management
Added 737,804$43M 0.1%Q2 2026
Ron Baron
Baron Capital (BAMCO)
Trimmed 650,686$38M 0.1%Q2 2026
Ken Fisher
Fisher Investments
Trimmed 682,711$31M 0.0%Q3 2026
Arrowstreet Capital Added 531,572$31M 0.0%Q2 2026
David Shaw
D. E. Shaw & Co.
Added 413,037$24M 0.0%Q2 2026
Alger
Fred Alger Management
Trimmed 321,311$19M 0.1%Q2 2026
Cliff Asness
AQR Capital Management
Added 149,648$9M 0.0%Q2 2026
Eddie Brown
Brown Capital Management
Held 96,023$4M 0.8%Q3 2026
Ray Dalio
Bridgewater Associates
Trimmed 58,289$3M 0.0%Q2 2026
Louis Bacon
Moore Capital Management
Trimmed 42,106$2M 0.1%Q2 2026
Joel Greenblatt
Gotham Asset Management
Trimmed 23,339$1M 0.0%Q2 2026
Man Group
Man Group plc
Trimmed 22,291$1M 0.0%Q2 2026
Acadian
Acadian Asset Management
Added 22,900$1M 0.0%Q3 2026
Paul Marshall
Marshall Wace
Trimmed 6,367$373,935 0.0%Q2 2026
Ensign Peak
Ensign Peak Advisors
Trimmed 4,515$265,166 0.0%Q2 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 202617
Q1 202621
Q4 202516
Q3 202512
Q2 202517
Q1 202517
Q4 202421
Q3 202419

Questions about Veracyte

Which superinvestors own Veracyte?

17 of the superinvestors we track hold Veracyte (VCYT) in their latest 13F filings, $671M in total. Artisan Partners, Cathie Wood, Steve Cohen, Ron Baron, Ken Fisher, Arrowstreet Capital.

Who is the largest superinvestor holder of VCYT?

The largest holder is Artisan Partners, with $325M, 0.5% of the portfolio.

From Veracyte's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind Veracyte and thousands of other companies, in one place. Free to start.